Sara Mangsbo is Founder and CSO of this company. She is active in the field of immunotherapy for over 10 years, with extensive knowledge of innate as well as adaptive immunity. Sara has experience of both pre-clinical and clinical studies and has worked with immune targeting mAbs as well as immune complexes and Fc receptors for many years. Sara has also held a position at AstraZeneca as Brand Lead of Immuno-oncology. Currently she heads a research group within Uppsala University.
Haematology